Firm Analyst
A.G.P./Alliance Global Partners
Jim Molloy
Barclays
Balaji Prasad
BMO Capital Markets
Gary Nachman
Cantor Fitzgerald
Brandon Folkes
JMP Securities
Roy Buchanan
Raymond James
Elliot Wilbur

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >
D-PLEX100

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >
D-PLEX1000

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >